GlassScriptPhysician profile
Cameron D Godfrey
NPI 1306824578
$1,507.97
in general payments reported to CMS, 2019-2025
23 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $185 · 2021: $67.37 · 2022: $92.69 · 2023: $229 · 2024: $161 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $424.78 | 2024-2025 | Pteye Parathyroid Detection System, Propel, Bizact |
| Regeneron Healthcare Solutions, INC. | $215.85 | 2019-2025 | Dupixent |
| Neurent Medical Limited | $145.64 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Smith+Nephew, INC. | $97.40 | 2020-2021 | |
| Stryker Corporation | $73.73 | 2019-2025 | Scopis Ent |
| Acclarent, INC | $65.72 | 2023 | Acclarent Aera |
| Inspire Medical Systems, INC. | $61.11 | 2023 | Inspire |
| Ethicon US, LLC | $57.37 | 2023-2025 | Echelon; Endopath, Echelon Circular, Echelon Endopath |
| Glaxosmithkline, LLC. | $38.17 | 2022 | |
| Optinose US, INC. | $38.00 | 2021-2022 | |
| Genzyme Corporation | $34.50 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $34.26 | 2025 | Keytruda |
| Aimmune Therapeutics, INC. | $27.24 | 2020 | |
| Intersect Ent, INC. | $25.52 | 2019 | |
| Olympus America INC. | $24.10 | 2024 | Connecting Tube |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.67 | 2019 | |
| Integra Lifesciences Corporation | $22.65 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aerin Medical INC. | $20.13 | 2022 | |
| Fujirebio Diagnostics, Incorporated | $19.35 | 2020 | |
| Cook Medical LLC | $17.04 | 2023 | Biodesign |
| Takeda Pharmaceuticals U.S.A., INC. | $16.00 | 2022 | |
| Cochlear Americas | $15.09 | 2020 | |
| Medline Industries LP | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Godfrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.